Evaluating the potential of combinatorial therapy with RNA polymerase I inhibitors to counteract chemotherapy-induced thrombocytopenia

Researchers

Grant status

Active

Grant start date

01/06/2022

Grant funding

  • 2022: $65,000 from ACT Cancer Council

Updated:  15 July 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers